DAE HWA Pharmaceutical Co., Ltd.

KOSDAQ:A067080 Voorraadrapport

Marktkapitalisatie: ₩216.3b

DAE HWA Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kim Eun-Seok

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO1.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

If You Like EPS Growth Then Check Out DAE HWA Pharmaceutical (KOSDAQ:067080) Before It's Too Late

Mar 22
If You Like EPS Growth Then Check Out DAE HWA Pharmaceutical (KOSDAQ:067080) Before It's Too Late

Should DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080) Be Part Of Your Dividend Portfolio?

Jan 28
Should DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080) Be Part Of Your Dividend Portfolio?

Do DAE HWA Pharmaceutical's (KOSDAQ:067080) Earnings Warrant Your Attention?

Dec 06
Do DAE HWA Pharmaceutical's (KOSDAQ:067080) Earnings Warrant Your Attention?

CEO

Kim Eun-Seok (49 yo)

no data

Tenure

Kim Eun-Seok serves as Chief Executive Officer and External Director of DAE HWA Pharmaceutical Co., Ltd., responsible for planning management. Kim Eun-Seok worked for Bukwang Pharmaceutical Ind. Co., Ltd....